当前位置:首页 - 行情中心 - 海利生物(603718) - 财务分析 - 现金流量表

海利生物

(603718)

  

流通市值:45.23亿  总市值:45.70亿
流通股本:6.49亿   总股本:6.56亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金119,075,211.0446,344,582.44229,033,898.88151,621,540.65
  收到其他与经营活动有关的现金19,636,166.883,640,860.9521,306,477.8315,288,557.78
  经营活动现金流入小计138,711,377.9249,985,443.39250,340,376.71166,910,098.43
  购买商品、接受劳务支付的现金13,662,246.035,136,427.5947,366,102.8736,610,832.69
  支付给职工以及为职工支付的现金43,130,285.3124,656,394.9371,116,740.9144,672,702.35
  支付的各项税费23,899,616.1316,216,806.7823,891,564.3316,496,012.38
  支付其他与经营活动有关的现金19,898,553.639,575,722.161,492,877.8847,448,027.1
  经营活动现金流出小计100,590,701.155,585,351.4203,867,285.99145,227,574.52
  经营活动产生的现金流量净额38,120,676.82-5,599,908.0146,473,090.7221,682,523.91
二、投资活动产生的现金流量:
  收回投资收到的现金224,053,774.46140,014,0001,163,227,548.7555,161,374.16
  取得投资收益收到的现金916,129.69761,376.48199,664,688.153,950,874.27
  处置固定资产、无形资产和其他长期资产收回的现金净额305,000---
  投资活动现金流入小计225,274,904.15140,775,376.481,362,892,236.85559,112,248.43
  购建固定资产、无形资产和其他长期资产支付的现金6,783,988.984,140,688.988,389,9586,939,464
  投资支付的现金227,064,000117,433,000538,000,000588,000,000
  取得子公司及其他营业单位支付的现金21,507,071.46-892,928.54768,330,381.96-
  支付其他与投资活动有关的现金--9,833,595.23-
  投资活动现金流出小计255,355,060.44120,680,760.441,324,553,935.19594,939,464
  投资活动产生的现金流量净额-30,080,156.2920,094,616.0438,338,301.66-35,827,215.57
三、筹资活动产生的现金流量:
  取得借款收到的现金--837,990,640.4758,413,429
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--837,990,640.4758,413,429
  偿还债务支付的现金--688,413,42983,500,000
  分配股利、利润或偿付利息支付的现金--21,573,173.720,333,995.76
  支付其他与筹资活动有关的现金12,611,233.4510,517,452.911,712,442.1-
  筹资活动现金流出小计12,611,233.4510,517,452.91711,699,044.8103,833,995.76
  筹资活动产生的现金流量净额-12,611,233.45-10,517,452.91126,291,595.67-45,420,566.76
四、汇率变动对现金及现金等价物的影响-700,708.9-236,827.9610,304,326.17-5,721.11
五、现金及现金等价物净增加额-5,271,421.823,740,427.16221,407,314.22-59,570,979.53
  加:期初现金及现金等价物余额358,500,504.83358,500,504.83137,093,190.61137,093,190.61
  期末现金及现金等价物余额353,229,083.01362,240,931.99358,500,504.8377,522,211.08
补充资料:
  净利润31,979,342.76-181,635,596.01-
  资产减值准备--3,714,782.36-
  固定资产和投资性房地产折旧2,643,853.48-21,744,102.35-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧2,643,853.48-21,744,102.35-
  无形资产摊销3,958,260.4-13,051,973.41-
  长期待摊费用摊销717,704.75-1,836,753.87-
  处置固定资产、无形资产和其他长期资产的损失-223,211.51---
  固定资产报废损失5,477.23-706,224.28-
  公允价值变动损失-1,501,099.14-12,761,890.33-
  财务费用1,472,800.39--4,813,340.39-
  投资损失-223,930.93--158,406,545.28-
  递延所得税-565,778.81-16,669,594.76-
  其中:递延所得税资产减少3,175.15-17,867,457.93-
    递延所得税负债增加-568,953.96--1,197,863.17-
  存货的减少-6,742,468.3-9,166,404.12-
  经营性应收项目的减少5,991,710.99--19,406,503.96-
  经营性应付项目的增加-2,702,503.46--59,206,983.76-
  其他--20,452,326.33-
  现金的期末余额353,229,083.01-358,500,504.83-
  减:现金的期初余额358,500,504.83-137,093,190.61-
  现金及现金等价物的净增加额-5,271,421.82-221,407,314.22-
公告日期2025-08-282025-04-222025-04-222024-10-31
审计意见(境内)标准无保留意见
TOP↑